IPR Stock Overview
Produces, processes, and commercializes novel antimicrobial coating products under the Pathoglaze name.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
IPERION Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$0.003 |
| 52 Week High | NZ$0.005 |
| 52 Week Low | NZ$0.003 |
| Beta | 0.047 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -62.50% |
| 5 Year Change | n/a |
| Change since IPO | -85.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| IPR | NZ Chemicals | NZ Market | |
|---|---|---|---|
| 7D | 0% | 2.8% | -0.7% |
| 1Y | n/a | 6.1% | 7.9% |
Return vs Industry: Insufficient data to determine how IPR performed against the NZ Chemicals industry.
Return vs Market: Insufficient data to determine how IPR performed against the NZ Market.
Price Volatility
| IPR volatility | |
|---|---|
| IPR Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 10.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in NZ Market | 10.0% |
| 10% least volatile stocks in NZ Market | 3.1% |
Stable Share Price: IPR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IPR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | iperion.co.nz |
IPERION Limited produces, processes, and commercializes novel antimicrobial coating products under the Pathoglaze name. The company’s products are used in furniture, egg cartons, kitchen chopping boards, and textiles, as well as used in automotive and hospitals sectors. IPERION Limited was formerly known as Southern Charter Financial Group Limited and changed its name to IPERION Limited in November 2023.
IPERION Limited Fundamentals Summary
| IPR fundamental statistics | |
|---|---|
| Market cap | NZ$1.54m |
| Earnings (TTM) | -NZ$812.26k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.9x
P/E RatioIs IPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IPR income statement (TTM) | |
|---|---|
| Revenue | NZ$0 |
| Cost of Revenue | NZ$0 |
| Gross Profit | NZ$0 |
| Other Expenses | NZ$812.26k |
| Earnings | -NZ$812.26k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0016 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did IPR perform over the long term?
See historical performance and comparison